Remove IPO Remove Stock Remove Workshop
article thumbnail

Cooley’s 2022 Life Sciences M&A Year in Review

Cooley M&A

Although there were 104 initial public offerings of biotechnology companies in 2021 that raised nearly $15 billion in funds, 2022 saw only 22 such IPOs collectively raising less than $2 billion. Let’s dig in. Activists may be able to take advantage of high trading volumes to accumulate positions without early detection.

M&A 40
article thumbnail

Spot Cyber & IT Challenges Through Improved Due Diligence

M&A Leadership Council

The risks of brand damage, customer churn, and substantial costs have brought this topic to the forefront in many recent M&A Leadership Council workshops. Prior to joining M&A Partners, Mark headed Innovation, Research & Development for U.S. Previously as CIO of JPMorgan-U.S.

IT 52
article thumbnail

Spot Cyber & IT Challenges

M&A Leadership Council

The risks of brand damage, customer churn, and substantial costs have brought this topic to the forefront in many recent M&A Leadership Council workshops. Cybersecurity and IT due diligence has become one of the most challenging, and also one of the most critical areas of due diligence in any environment.

IT 52